Predictive Factors of Clinical Response to Cholinesterase Inhibitors in Mild and Moderate Alzheimer's Disease and Mixed Dementia: A One-Year Naturalistic Study-Reference-Cited by-同舟云学术

Predictive Factors of Clinical Response to Cholinesterase Inhibitors in Mild and Moderate Alzheimer's Disease and Mixed Dementia: A One-Year Naturalistic Study

Published:2015-03-18 Issue:2 Volume:45 Page:609-620
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Miranda Luís F.J.R.¹,Gomes Karina B.²,Silveira Josianne N.²,Pianetti Gerson A.²,Byrro Ricardo M.D.²,Peles Patrícia R.H.³,Pereira Fernando H.¹,Santos Thiago R.⁴,Assini Arthur G.²,Ribeiro Valéria V.²,Tito Pedro A.L.⁵,Matoso Rafael O.¹,Lima Thiago O.L.¹,Moraes Edgar N.¹⁶,Caramelli Paulo¹³

Affiliation:

1. Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte (MG), Brasil

2. Faculdade de Farmácia da Universidade Federal de Minas Gerais, Belo Horizonte (MG), Brasil

3. Serviço de Neurologia do Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte (MG), Brasil

4. Instituto de Ciências Exatas da Universidade Federal de Minas Gerais, Belo Horizonte (MG), Brasil

5. Instituto de Ciências Biológicas da Universidade Federal de Minas Gerais, Belo Horizonte (MG), Brasil

6. Serviço de Geriatria do Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte (MG), Brasil

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotection of Multitargeted Phytochemicals against Alzheimer: A Desperate Need from Nature;The Natural Products Journal;2023-08

2. Translating clinical notes into quantitative measures—a real-world observation on the response to cholinesterase inhibitors or selective serotonin reuptake inhibitors prescribed to outpatients with dementia using electronic medical records;Frontiers in Pharmacology;2023-05-10

3. Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases;Ageing Research Reviews;2023-02

4. Advances in pharmacogenomics for personalized emergency medicine;International journal of health sciences;2023-01-15

5. Genetic Contributions and Personalized Medicine;Chronic Illness Care;2023